Recursion Pharmaceuticals RXRX and Schrodinger SDGR are pioneering the use of artificial intelligence (AI) in drug discovery for various indications across different disease areas. They leverage ...

Figure 5. Association of the NF-κB signaling pathway with the mechanisms of selinexor resistance. Selinexor is showing great potential in the treatment of AML, especially for relapsed/refractory ...

Over the last decade there has been an extraordinary increase in our knowledge of the fundamental molecular processes that are involved in the development of cancer and its response to treatment ...

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) has achieved a major milestone in the fight against acute myeloid leukemia (AML), announcing today the successful dosing of the first patient in its ...

The marks can be a sign of Neurofibromatosis (NF) type 1. Doctors at the Children's Hospital of Philadelphia confirmed that's what Mila had, which led to several follow-up appointments.

The European Commission has approved Astellas’ Xospata (gilteritinib) for patients with relapsed or refractory FLT3-positive acute myeloid leukemia (AML), cementing its lead over a rival drug ...

The vast majority of the AML-related fines of the last two years have been dealt with in-house but this was deemed more significant. The tribunal heard that a desk-based review was conducted by ...

Panelists discuss the critical role of psychosocial support in managing NF1-associated plexiform neurofibromas, emphasizing the need for psychotherapy, counseling, and social work interventions to ...